R&D Strategy
Portfolio shaping, asset positioning, and evidence planning anchored by proprietary models and disciplined scenario design.
AI-Native Biotech Consulting
Phintel convenes McKinsey- and BCG-honed consulting craft, biotech operator experience, and agentic AI loops to strip ambiguity out of critical decisions before competitors move.
We interrogate R&D, clinical, and BD inflection points, synthesizing nuanced data, trial breadcrumbs, and market sentiment on targets, modalities, and deal terms so teams aren't blindsided.
Work ranges from fast decision sprints to longer embeds that evolve alongside pipelines, data readouts, and rival moves.
Every engagement is run by one or two high-agency partners—former top-tier consultants and operators with advanced degrees—who stay on the work end to end.
Disciplined strategy, clinical, and BD support that pairs proprietary AI agents with measured human judgment.
Portfolio shaping, asset positioning, and evidence planning anchored by proprietary models and disciplined scenario design.
Protocol refinement, comparator selection, and operational risk surfacing that blends expert intuition with real-time data pulls.
Diligence sprint teams uncover signals in crowded landscapes—tracking modalities, deal terms, and emerging competitors.
Custom agents automate research loops, maintain living dossiers, and keep leadership synced on what matters next.
A flexible working rhythm that keeps decision-makers informed while we run deep research loops in the background.
We take on a limited number of concurrent clients to stay close to the science
and the decisions that follow; if you're looking for an outcome-focused partner, reach out.